SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $28.06MP/E –Yield –
Scynexis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Scynexis's revenue for the twelve months ending Jun 30, 2026 was $19.22M, up 489.8% year over year. For fiscal 2025 it was $20.60M, up 449.9% from the year before. Over ten years it grew 55.0% a year on average. The highest annual figure on record is $140.14M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.60M | +449.9% |
| FY2024 | Dec 31, 2024 | $3.75M | -97.3% |
| FY2023 | Dec 31, 2023 | $140.14M | +2652.7% |
| FY2022 | Dec 31, 2022 | $5.09M | -61.3% |
| FY2021 | Dec 31, 2021 | $13.16M | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $121.00K | -52.9% |
| FY2018 | Dec 31, 2018 | $257.00K | 0.0% |
| FY2017 | Dec 31, 2017 | $257.00K | 0.0% |
| FY2016 | Dec 31, 2016 | $257.00K | 0.0% |
| FY2015 | Dec 31, 2015 | $257.00K | -79.5% |
| FY2014 | Dec 31, 2014 | $1.26M | -92.5% |
| FY2013 | Dec 31, 2013 | $16.86M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $235.00K | -82.8% |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $18.65M | +1808.5% |
| Q3 FY2025 | Sep 30, 2025 | $334.00K | -49.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.36M | +85.3% |
| Q1 FY2025 | Mar 31, 2025 | $257.00K | -81.3% |
| Q4 FY2024 | Dec 31, 2024 | $977.00K | -83.1% |
| Q3 FY2024 | Sep 30, 2024 | $660.00K | -62.5% |
| Q2 FY2024 | Jun 30, 2024 | $736.00K | -99.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.37M | +21.5% |
| Q4 FY2023 | Dec 31, 2023 | $5.80M | +280.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.76M | +13.1% |
| Q2 FY2023 | Jun 30, 2023 | $131.45M | +9836.1% |
| Q1 FY2023 | Mar 31, 2023 | $1.13M | +64.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.52M | +155.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.56M | +201.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.32M | – |
| Q1 FY2022 | Mar 31, 2022 | $687.00K | -94.3% |
| Q4 FY2021 | Dec 31, 2021 | $597.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $516.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $12.05M | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $0 | -100.0% |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $57.00K | -10.9% |
| Q1 FY2019 | Mar 31, 2019 | $64.00K | 0.0% |
| Q4 FY2018 | Dec 31, 2018 | $64.00K | 0.0% |
| Q3 FY2018 | Sep 30, 2018 | $64.00K | 0.0% |
| Q2 FY2018 | Jun 30, 2018 | $64.00K | 0.0% |
| Q1 FY2018 | Mar 31, 2018 | $64.00K | 0.0% |
| Q4 FY2017 | Dec 31, 2017 | $64.00K | -1.5% |
| Q3 FY2017 | Sep 30, 2017 | $64.00K | 0.0% |
| Q2 FY2017 | Jun 30, 2017 | $64.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $64.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $65.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $64.00K | – |
See a number that looks wrong?